Lindsay Rosenwald

Lindsay Rosenwald serves as Chief Executive Officer at Fortress Biotech. Fortress Biotech operates in the research sector with approximately 24.0 employees. The company is headquartered in New York, New York. Fortress Biotech generates annual revenue of 57675000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 6,952 executive contacts are available in New York.
• • Our database includes 201,468 c suite-level executives.

Outlook Amazon AWS Microsoft Office 365 Apache Mobile Friendly WordPress.org Google Tag Manager Google Analytics Google Font API Remote Splunk AI

biotechnology: pharmaceutical preparations health care biotechnology research biopharmaceutical drug development clinical trials marketed products pipeline partnerships oncology neurology gene therapy rare diseases pain management infectious diseases dermatology cns disorders royalty fda approval nda commercialization therapeutic areas investor relations clinical-stage preclinical drug candidates acute pain chronic pain treatment disease prevention patients drug safety biotech innovation development market strategy long-term revenue medical solutions therapeutic solutions car t therapy molecular therapy genetic disorders antibody treatment immunotherapy cell therapy quality assurance market access investments clinical pipelines medical technology healthcare solutions biotech partnerships health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Lindsay Rosenwald in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Fortress Biotech.

Lindsay Rosenwald's Position in the MessageCEO Database

• •Lindsay Rosenwald is 1 of 1 verified executive contact we track at Fortress Biotech.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •6,778 verified executive contacts in New York are in the database.
• •54 verified contacts work at research companies in the 24.0 employee range (same size as Fortress Biotech).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Lindsay Rosenwald directly?

Lindsay Rosenwald's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Fortress Biotech. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Lindsay Rosenwald work for?

Lindsay Rosenwald is Chief Executive Officer at Fortress Biotech, a company in the research sector with 24.0 employees. The company is based in New York, New York.

Can I pitch or sell to Lindsay Rosenwald?

As Chief Executive Officer at Fortress Biotech, Lindsay Rosenwald is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Lindsay Rosenwald directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Lindsay Rosenwald in?

Lindsay Rosenwald works in the research industry as Chief Executive Officer at Fortress Biotech. MessageCEO provides verified contact information for executives across all major industries.

Is Lindsay Rosenwald's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Lindsay Rosenwald's profile is kept up-to-date with the latest available information.

Last updated: July 27, 2026